Resultados da busca - Natalia Aptsiauri
- Mostrando 1 - 16 resultados de 16
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture por Federico Garrido, Francisco Perea, Mónica Bernal, Abel Sánchez‐Palencia, Natalia Aptsiauri, Francisco Ruíz-Cabello
Publicado em 2017Revisão -
10
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations por Natalia Aptsiauri, Rafael Carretero, Ángel M. García-Lora, Luís Miguel Real, Teresa Cabrera, Federico Garrido
Publicado em 2008Revisão -
11
-
12
Bacillus Calmette‐Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I‐deficient tumor cells por Rafael Carretero, Teresa Cabrera, Hernani Gil, Pablo Sáenz-López, Isabel Maleno, Natalia Aptsiauri, J.M. Cózar, Federico Garrido
Publicado em 2010Artigo -
13
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank por Rosa Méndez, Natalia Aptsiauri, Ana Del Campo, Isabel Maleno, Teresa Cabrera, Francisco Ruíz-Cabello, Federico Garrido, Ángel M. García-Lora
Publicado em 2009Revisão -
14
Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma por Ana Belén Campo, Jon Amund Kyte, Javier Carretero, Svitlana Zinchencko, Rosa Méndez, Gloria González‐Aseguinolaza, Francisco Ruíz-Cabello, Steinar Aamdal, Gustav Gaudernack, Federico Garrido, Natalia Aptsiauri
Publicado em 2013Artigo -
15
HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape por Francisco Perea, Abel Sánchez‐Palencia, Mercedes Gómez‐Morales, Mónica Bernal, Ángel Concha, Míguela Méndez García, Amanda Rocío González Ramírez, Martin Kerick, Javier Martı́n, Federico Garrido, Francisco Ruíz-Cabello, Natalia Aptsiauri
Publicado em 2017Artigo -
16
ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring—even in hands of ELISPOT-inexperienced investigators por W. Zhang, Richard Caspell, Alexey Y. Karulin, Murrium Ahmad, Nacilla Haicheur, Ahmed Abdelsalam, K. Johannesen, Virginie Vignard, Paulina Dudzik, K. Georgakopoulou, A. Mihaylova, Karīna Siliņa, Natalia Aptsiauri, Val R. Adams, P. Lehmann, Stéphanie McArdle
Publicado em 2009Artigo
Ferramentas de busca:
Assuntos relacionados
Biology
Immunology
Cancer research
Immune system
Medicine
Antigen
Human leukocyte antigen
Immunotherapy
Cancer
Genetics
Cancer immunotherapy
MHC class I
Major histocompatibility complex
CD8
Gene
In vitro
Internal medicine
Biochemistry
Cytotoxic T cell
Pathology
Allele
Loss of heterozygosity
T cell
Cell culture
Computer science
Melanoma
Tumor microenvironment
Tumor-infiltrating lymphocytes
Antigen presentation
Artificial intelligence